Currently the price is 0,80$, Kezar Life Sciences Inc is a company created in United States dedicated to Biotechnology: Pharmaceutical Preparations with its highest number of sales in North America. Its Executives are Christopher J. Kirk (President, Director & Chief Scientific Officer), John Fowler (Chief Executive Officer & Director), Marc L. Belsky (Chief Financial Officer & Secretary), Michael Wolfe (Director-Finance & Business Operations), Noreen Roth Henig (Chief Medical Officer) and its address is 4000 SHORELINE COURT SUITE 300, SOUTH SAN FRANCISCO, California, 94080, United States.

Today this action begins with yesterday's closing price, desconocido$.

The current range on the same day is from 0,73$ - 0,81$, with a percentage difference of 0,77$ quite wide that helps to be able to do day trading.

The company has an annual revenue of desconocido.

The last value we have registered for the opening is desconocido.

If we think of formulas to know when to buy or sell a stock, a value that appears in them always comes to mind, which is the range between the lowest and the highest price that the stock has obtained, for example, here it has been between 0,00$ and 0,00$.

EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].